{"transactions":[{"id":961738,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-19T22:20:50.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":54000,"derivative":{"exercise_price":6.52,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001193805-25-001764","document":"e665058_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380525001764/e665058_4-kurata.xml","form_type":"4"}},{"id":1326107,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-18T21:07:29.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":60000,"derivative":{"exercise_price":16.24,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193805-24-001493","document":"e664086_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524001493/e664086_4-kurata.xml","form_type":"4"}},{"id":1704127,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-20T01:01:03.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":75000,"derivative":{"exercise_price":28.88,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001193805-23-001628","document":"e619135_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380523001628/e619135_4-kurata.xml","form_type":"4"}},{"id":2087395,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-13T21:05:51.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock approved by the Board of Directors on December 9, 2022 pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 9, 2023, the first anniversary of the date this award was approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":125000,"derivative":{"exercise_price":16.92,"expiration_date":"2032-12-09","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193805-22-001713","document":"e618106_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380522001713/e618106_4-kurata.xml","form_type":"4"}},{"id":2222679,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-23T20:15:52.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock conditionally approved by the Board of Directors on December 10, 2021, subject to approval of an amendment to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan by the Company's stockholders, which approval was obtained at the Company's 2022 Annual Meeting of Stockholders held on June 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 10, 2022, the first anniversary of the date this award was conditionally approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":50000,"derivative":{"exercise_price":34.57,"expiration_date":"2031-12-10","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193805-22-000999","document":"e621770_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380522000999/e621770_4-kurata.xml","form_type":"4"}},{"id":2934067,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-23T00:37:47.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":25000,"derivative":{"exercise_price":99.29,"expiration_date":"2030-12-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193805-20-001606","document":"e620160_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380520001606/e620160_4-kurata.xml","form_type":"4"}},{"id":3059648,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71069,"kind":"person","name":"Kurata Lance","position":1,"cik":"0001820961","reported_name":"Kurata Lance","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-13T00:38:43.000Z","date":"2020-08-10","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on August 10, 2021, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":90000,"derivative":{"exercise_price":58.91,"expiration_date":"2030-08-09","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001193805-20-001022","document":"e619870_4-kurata.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380520001022/e619870_4-kurata.xml","form_type":"4"}}]}